Anticancer, anti-biofilm and antimicrobial activity of fucoidan-loaded zeolitic imidazole framework fabricated by one-pot synthesis method

Acute toxicity of nanoscale zeolitic imidazolate framework 8 (ZIF-8) to saltwater planktonic species Artemia salina and Nannochloropsis oculata

Zeolitic imidazolate framework-8 nanoparticles (ZIF-8 NPs) are metal-organic frameworks (MOFs) that have gained significant attention in various fields due to their unique properties. They have potential applications in drug delivery, gas storage, and catalysis. However, their increasing use raises concerns about their potential environmental impact. Our study evaluates the effects of ≈90 nm ZIF-8 NPs in two planktonic species, the green microalga Nannochloropsis oculata and the brine shrimp Artemia salina. After synthesis and characterization (SEM, EDS, BET, and DLS) of nanoporous ZIF-8 NPs, a growth inhibition test on microalgae (72 h) and acute immobilization test on instar I and II of Artemia nauplii (48 h) were conducted following, OECD 201 and ISO/TS 20787, respectively. The toxicity of ZIF-8 NPs to both species was time- and concentration-dependent. The 72-h median inhibitory concentration (IC50) of ZIF-8 NPs for N. oculata based on average specific growth rate and yield were calculated as 79.71 ± 8.55 mg L-1 and 51.73 ± 5.16 mg L-1, respectively. Also, the 48-h median effective concentration (EC50) of ZIF-8 NPs on immobilization rate of instar I and II were calculated as 175.09 ± 4.14 mg L-1 and 4.69 ± 0.34 mg L-1, respectively. Moreover, the swimming type of non-immobilized animals was affected by ZIF-8 NPs. These findings provide a good insight into the toxicity of nanoparticulate ZIF-8 to saltwater planktons and also confirm that instar II Artemia is more sensitive than instar I. This study demonstrated that ZIF-8 NPs, despite all their advantages, could have toxic effects on aquatic organisms. More studies are required to assess their potential environmental impact and develop strategies to mitigate their toxicity.

Oxymatrine-mediated prevention of amyloid β-peptide-induced apoptosis on Alzheimer's model PC12 cells: in vitro cell culture studies and in vivo cognitive assessment in rats

Alzheimer's disease (AD) is a major neurological disease affecting elderly individuals worldwide. Existing drugs only reduce the symptoms of the disease without addressing the underlying causes. Commonly, Aβ25-35 peptide aggregation is the main reason for AD development. Recently, the discovery of multiple protein-targeting molecules has provided a new strategy for treating AD. This study demonstrates the neuroprotective potential of oxymatrine against multiple mechanisms, such as acetylcholinesterase, mitochondrial damage, and β-amyloid-induced cell toxicity. The in vitro cell culture studies showed that oxymatrine possesses significant potential to inhibit acetylcholine esterase and promotes antioxidant, antiapoptotic effects while preventing Aβ25-35 peptide aggregation in PC12 cells. Furthermore, oxymatrine protects PC12 cells against Aβ25-35-induced cytotoxicity and down-regulates the reactive oxygen species generation. The in vivo acute toxicological studies confirm the safety of oxymatrine without causing organ damage or death in animals. Overall, this study provided evidence that oxymatrine is an efficient neuroprotective agent, with a potential to be a multifunctional drug for Alzheimer's disease treatment. These findings present a reliable and synergistic approach for treating AD.

Fucoidan-Containing, Low-Adhesive Siloxane Coatings for Medical Applications: Inhibition of Bacterial Growth and Biofilm Development

The deposition of low-adhesive siloxane coatings is a current trend for the non-toxic control of bacterial growth and biofilm formation. Total elimination of biofilm formation has not been reported so far. The aim of this investigation was to study the ability of a non-toxic, natural, biologically active substance, such as fucoidan, to inhibit bacterial growth on similar medical coatings. The fucoidan amount was varied, and its impact on the bioadhesion-influencing surface characteristics, as well as on bacterial cell growth, was investigated. The inclusion of up to 3-4 wt.% brown algae-derived fucoidan in the coatings increases their inhibitory effect, more significantly on the Gram-positive bacterium S. aureus than on the Gram-negative bacterium Escherichia coli. The biological activity of the studied siloxane coatings was ascribed to the formation of a low-adhesive, biologically active surface top layer consisting of siloxane oil and dispersed water-soluble fucoidan particles. This is the first report on the antibacterial activity of fucoidan-containing medical siloxane coatings. The experimental results give reason to expect that relevantly selected, natural biologically active substances can be efficient in the non-toxic control of bacterial growth on medical devices and, as a result, medical device-associated infections.

Facile Fabrication of Methyl Gallate Encapsulated Folate ZIF-L Nanoframeworks as a pH Responsive Drug Delivery System for Anti-Biofilm and Anticancer Therapy

Zeolitic imidazole frameworks are emerging materials and have been considered an efficient platform for biomedical applications. The present study highlights the simple fabrication of methyl gallate encapsulated folate-ZIF-L nanoframeworks (MG@Folate ZIF-L) by a simple synthesis. The nanoframeworks were characterized by different sophisticated instruments. In addition, the drug-releasing mechanism was evidenced by in vitro releasing kinetics at various pH conditions. The anti-biofilm potential confirmed by the biofilm architectural deformations against human infectious pathogens MRSA and N7 clinical strains. Furthermore, anticancer efficacy assessed against A549 lung cancer cells. The result reveals that the MG@Folate ZIF-L exposed a superior cytotoxic effect due to the pH-responsive and receptor-based drug-releasing mechanism. Based on the unique physicochemical and biological characteristics of nanoframeworks, it has overcome the problems of undesired side effects and uncontrolled drug release of existing drug delivery systems. Finally, the in vitro toxicity effect of MG@Folate ZIF-L was tested against the Artemia salina (A. salina) model organism, and the results show enhanced biocompatibility. Overall, the study suggested that the novel MG@Folate ZIF-L nanoframeworks is a suitable material for biomedical applications. It will be very helpful to the future design for targeted drug delivery systems.